This is a news story, published by Investor's Business Daily, that relates primarily to Skyrizi news.
For more Skyrizi news, you can click here:
more Skyrizi newsFor more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsFor more news from Investor's Business Daily, you can click here:
more news from Investor's Business DailyOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
AbbVie stock. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Skyrizi revenue news, stock news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
AbbVieInvestor's Business Daily
•Business
Business & Economics
79% Informative
AbbVie ( ABBV ) stock surged early Friday after the pharma giant reported adjusted earnings of $ 2.16 per share on $15.1 billion in fourth-quarter sales.
Skyrizi revenue rocketed nearly 58% vs. the year-earlier period, while Rinvoq sales jumped more than 46% .
VR Score
86
Informative language
91
Neutral language
3
Article tone
formal
Language
English
Language complexity
25
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
1
Source diversity
1
Affiliate links
no affiliate links
Small business owner?
